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Abstract
Objective
Scientific research is constantly striving to find molecules which are effective against exces-
sive body fat and its associated complications. Taking into account the beneficial effects
that resveratrol exerts on other pathologies through miRNA, the aim of the present work
was to analyze the possible involvement of miRNAs in the regulation of adipogenic tran-
scription factors peroxisome proliferator-activated receptor γ (pparγ), CCAAT enhancer-bind-
ing proteins α and β (cebpβ and cebpα) induced by resveratrol and its metabolites.
Methods
3T3-L1 maturing pre-adipocytes were treated during differentiation with 25 μM of trans-res-
veratrol (RSV), trans-resveratrol-3-O-sulfate (3S), trans-resveratrol-3’-O-glucuronide (3G)
and trans-resveratrol-4’-O-glucuronide (4G). After computational prediction and biblio-
graphic search of miRNAs targeting pparγ, cebpβ and cebpα, the expression of microRNA-
130b-3p (miR-130b-3p), microRNA-155-5p (miR-155-5p), microRNA-27b-3p (miR-27b-3p),
microRNA-31-5p (miR-31-5p), microRNA-326-3p (miR-326-3p), microRNA-27a-3p (miR-
27a-3p), microRNA-144-3p (miR-144-3p), microRNA-205-5p (miR-205-5p) and microRNA-
224-3p (miR-224-3p) was analyzed. Moreover, other adipogenic mediators such as sterol
regulatory element binding transcription factor 1 (srebf1), kru¨ppel-like factor 5 (klf5), liver x
receptor α (lxrα) and cAMP responding element binding protein 1 (creb1), were measured
by Real Time RT-PCR. As a confirmatory assay, cells treated with RSV were transfected
with anti-miR-155 in order to measure cebpβ gene and protein expressions.
Results
Of the miRNAs analyzed only miR-155 was modified after resveratrol and glucuronide
metabolite treatment. In transfected cells with anti-miR-155, RSV did not reduce cebpβ
gene and protein expression. 3S decreased gene expression of creb1, klf5, srebf1 and lxrα.
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Conclusions
While RSV and glucuronide metabolites exert their inhibitory effect on adipogenesis through
miR-155 up-regulation, the anti-adipogenic effect of 3S is not mediated via miRNAs.
Introduction
Obesity is a genuinely serious real health problem. In 2014 about 13% of the world’s adult pop-
ulation worldwide (11% of men and 15% of women) suffered from obesity [1]. In addition,
this pathology induces a great number of co-morbilities, such as type 2 diabetes, dyslipidemia,
hypertension and cancer among others. Consequently, direct and indirect costs associated
with these common medical conditions have charted a steady rise in obesity costs over the
years, as the epidemic has grown.
Adipose tissue growth in obesity can be mediated by hypertrophy, which is to say an
increase in adipocyte size and/or hyperplasia, that is an increase in adipocyte number. When
hyperplasia takes place there is a stimulation of pre-adipocyte proliferation and further differ-
entiation. The above process, which promotes pre-adipocyte differentiation into mature adi-
pocytes (2) plays a crucial role in the development of obesity and needs to be highly controlled.
It is well established that in the long term continued energy overloading can increase this pro-
cess, mainly in young subjects [2]. Although several molecular aspects of adipogenesis are still
unknown, peroxisome proliferator-activated receptor γ (pparγ) has been identified as the mas-
ter coordinator of adipocyte differentiation[3]. The control that pparγ exerts over pre-adipo-
cytes for them to reach adipocyte functionally needs the expression of other important genes
both at the early and at the latter stages of adipocyte differentiation, such as CCAAT enhancer-
binding proteins α and β (cebpβ and cebpα) respectively [4, 5].
These adipogenic genes are regulated by different mechanisms, microRNAs (MiRNAs)
among others. MiRNAs are small non-coding RNAs about 19–23 nucleotides in length that
have emerged as important regulators of gene expression [6]. They act by base paring with
their target mRNA, which leads to mRNA degradation or translation repression [7, 8]. More
than 2500 miRNAs have been described in humans to date [9]. Some of them are involved in
numerous physiological and pathological processes, such as energy homeostasis [10], sugar
and lipid metabolism [11, 12] and tumorigenesis [13]. As far as adipose tissue is concerned,
several studies have concluded that some miRNAs can regulate adipogenesis by targeting
genes that regulate this process [14–16].
Scientific research is constantly being undertaken with the aim of finding new molecules,
either drugs or food components, which are effective in preventing excess accumulation of
body fat and associated complications. This is the case of trans-resveratrol (3,4,5-trihydroxys-
tilbene, RSV), a polyphenol with a stilbene structure that consists of two phenolic rings held
together by a double styrene bond. This compound is naturally present in various plants,
including grapes, berries and peanuts and is produced in response to stress, as a defence
mechanism against fungal, viral, bacterial infections and damage from exposure to ultraviolet
radiation [17]. Most RSV undergoes rapid and extensive metabolism into enterocytes, before
entering blood. Furthermore, it undergoes rapid first-pass metabolism in the liver [17].
Consequently, RSV bioavailability is very low and only a small proportion reaches plasma. The
concentrations of glucuronide and sulfate metabolites are relatively higher [18–20]. The pro-
portions of glucuronide and sulfate metabolites depend on the tissue [21] and the species [22].
RSV, which shows antioxidant and antiinflammatory properties, is effective in the prevention
miRNA modification induced by resveratrol and its metabolites
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of several diseases including cardiovascular diseases, diabetes, cancer and recently, obesity.
With regard to obesity, a general consensus concerning the body-fat lowering effect of resvera-
trol in mice and rats exists [23, 24]. This effect is mainly mediated by a reduction in adipogen-
esis and lipogenesis and by an increase in energy expenditure, lipolysis and fatty acid
oxidation in liver and skeletal muscle [24].
Given the above relating to RSV metabolism, an important question is whether RSV metab-
olites are active molecules. In a previous study we described how RSV, as well as certain metab-
olites (trans-resveratrol-3-O-sulfate -3S-, trans-resveratrol-3’-O-glucuronide -3G- and trans-
resveratrol-4’-O-glucuronide -4G-) were able to modify the expression of genes related to the
adipogenic process [25]. While all of them (RSV, 3G, 4G and 3S) reduced cebpβ mRNA levels,
only the sulfate metabolite reduced cebpα and pparγ gene expression.
In this scenario and taking into account that the beneficial effects of RSV on other patholo-
gies, such as cancer and diabetes, are mediated by miRNA [26, 27], the present study focuses
on the possible involvement of different miRNAs in the changes induced by RSV and its
metabolites in adipogenic transcription factors pparγ, cebpβ and cebpα, a process which has
not been analyzed to date. For this purpose, a well-defined pre-adipocyte model, 3T3-L1
murine adipocytes, was used.
Material and methods
Experimental design and cell treatment
The experimental design for 3T3-L1 maturing pre-adipocyte was previously described (25).
Briefly, cells grown in 6-well plates were incubated with either 0.1% ethanol (95%) (control
group) or with RSV, 3G, 4G or 3S, all of them provided by Bertin Pharma (Montigny le Bre-
tonneux, France), at 25 μM (diluted in 95% ethanol) during the adipogenic phase from day 0
to day 8 of differentiation. The medium was changed every two days. On day 8, supernatant
was removed and cells were used for triacylglycerol determination and RNA extraction. Each
experiment was performed 3 times.
MiRNAs selection
For miRNAs selection as potential regulators of cebpβ, cebpα, pparγ, two criteria were estab-
lished: a) to be validated or predicted by five algorithms (miRanda, miRDB, miRWalk, RNA22
and Targetscan algorithms) in miRWalk 2.0. database [28] and b) to be reported in Pubmed
search using “miR + adipogenesis” terms (Table 1).
miRNA transfection
3T3-L1 pre-adipocytes at a confluence of approximately 80% were transfected with the Deli-
verXTM Plus siRNA Transfection Kit (Affimetrix, Santa Clara, CA) following the manufac-
turer´s protocol with mirVana miRNA inhibitor mmu-miR-155-5p or mirVana miRNA
inhibitor Negative Control (Applied Biosystems, Foster City, CA, USA). The final concentra-
tion of miRNA Inhibitors was established at 30 nM and the transfection period at 48 hours.
These optimal conditions were determined in previous experiments carried out at 24, 48 and
72 hours in cells at different confluence statuses, and transfection efficiency was assessed using
miRNA probes and fluorescent transfection controls.
At the same time, cells were stimulated to differentiate with DMEM containing 10% FCS,
10 μg/mL insulin, 0.5 mM isobutylmethylxanthine (IBMX), and 1 μM dexamethasone and
treated with RSV at 25 μM or ethanol 95% (Control group) during 48 hours. Afterwards, the
miRNA modification induced by resveratrol and its metabolites
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supernatant was removed and cells were used to RNA and protein extraction. Each experiment
was performed 3 times.
Extraction and analysis of RNA and quantification by Real Time reverse
transcription-polymerase chain reaction (Real Time RT-PCR)
Total RNA sample containing small and large-size RNA from maturing pre-adipocytes was
extracted with miRNeasy™ RNA isolation kit (Qiagen, Hilden, Germany) according to the
manufacturer’s protocol. Small-size RNA was used for miRNA expression analysis and large-
size RNA to quantify the mRNA expression.
1.5 μg of large-size RNA of each sample was reverse-transcribed to first-strand complemen-
tary DNA (cDNA) using iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). Sterol
regulatory element binding transcription factor 1 (srebf1), kru¨ppel-like factor 5 (klf5), liver x
receptor α (lxrα) and cAMP responding element binding protein 1 (creb1) mRNA levels were
quantified using Real-Time PCR with an iCyclerTM–MyiQTM Real-Time PCR Detection Sys-
tem (BioRad, Hercules, CA, USA) in the presence of SYBRGreen master mix (Applied Biosys-
tems, Foster City, CA, USA). All sample mRNA levels were normalized to the values of 18S
(Table 2).
Reverse transcription of 10 ng of small-size RNA and PCR were performed with the Taq-
Man1 MicroRNA Assay kit according to the manufacturer’s instructions (Applied Biosys-
tems, Foster City, CA, USA). miRNA levels for miR-130b-3p, miR-155-5p, miR-27b-3p, miR-
Table 1. miRNAs whose target genes have been predicted or validated by means of the miRWalk 2.0 or reported in the literature.
miRNA Validated target genes Predicted target genes (5 algorithms) Literature Mir+adipogenesis
mmu-miR-31-5p cebpα [29, 30]
mmu-miR-101a-3p cebpα -
mmu-miR-101b-3p cebpα -
mmu-miR-124-3p cebpα cebpα -
mmu-miR-130b-3p pparγ [15, 31–33]
mmu-miR-144-3p cebpα [34]
mmu-miR-155-5p cebpβ [16, 35–37]
mmu-miR-190a-5p cebpα -
mmu-miR-190b-5p cebpα -
mmu-miR-205-5p cebpα [38]
mmu-miR-224-3p cebpα [39]
mmu-miR-27a-3p pparγ pparγ [40, 41]
mmu-miR-27b-3p pparγ pparγ [42–46]
mmu-miR-326-3p cebpα [47]
mmu-miR-329-3p cebpα -
mmu-miR-330-5p cebpα -
mmu-miR-362-3p cebpα -
mmu-miR-466f-5p cebpβ -
mmu-miR-466i-3p cebpα -
mmu-miR-466m-3p cebpα -
mmu-miR-466o-3p cebpα -
mmu-miR-671-5p cebpα -
mmu-miR-690 cebpα -
CEBP α and β: Relative CCAAT enhancer-binding protein α and β; PPARγ: peroxisome proliferator-activated receptor γ.
https://doi.org/10.1371/journal.pone.0184875.t001
miRNA modification induced by resveratrol and its metabolites
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326-3p, miR-31-5p, miR-27a-3p, miR-144-3p, miR-205-5p and miR-224-3p were quantified
using TaqMan1 MicroRNA Assay (Applied Biosystems, Foster City, CA, USA) for each
miRNA and normalized to the values of U6 snRNA. The miRNA assay sequences were as
follows:
miR-130b-3p 5’- CAGUGCAAUGAUGAAAGGGCAU -3’
miR-155-5p 5’- UUAAUGCUAAUUGUGAUAGGGGU-3’
miR-27b-3p 5’- UUCACAGUGGCUAAGUUCUGC -3’
miR-326-3p 5’- CCUCUGGGCCCUUCCUCCAGU-3’
miR-31-5p 5’- AGGCAAGAUGCUGGCAUAGCUG-3’
miR-27a-3p 5’- UUCACAGUGGCUAAGUUCCGC—3’
miR-144-3p 5’- UACAGUAUAGAUGAUGUACU—3’
miR-205-5p 5’- UCCUUCAUUCCACCGGAGUCUG—3’
miR-224-3p 5’- AAAUGGUGCCCUAGUGACUACA—3’
All gene and miRNA expression results were expressed as fold changes of threshold cycle
(Ct) value relative to controls using the 2-ΔΔCt method [48].
After miRNA transfection assay, total RNA sample containing small and large-size RNA
was extracted with miRNeasy™ RNA isolation kit (Qiagen, Hilden, Germany). Small-size RNA
was used to mir-155 expression analysis and large-size RNA to quantify the mRNA expression
of cebpβ. The expression levels of both mir-155 and cebpβ were analyzed as explained before.
Protein expression analysis
Total protein was isolated from maturing 3T3-L1 adipocytes using 150 μL of lysis buffer (2 nM
tris-HCl, 0.1 M sodium chloride (NaCl), 1% Triton, 10% glycerol, 1 mM sodium orthovana-
date (OvNa), 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM sodium fluo-
ride (FNa) and 1% protease inhibitor) and centrifuged (12.000g, 15 minutes, 4˚C) to remove
membranes and other proteic residues. Protein concentration was determined by BCA protein
assay kit (Thermo Scientific, Wilmington, DE, USA). Total protein (20 μg) was subjected to
10% SDS-polyacrylamide gel, electroblotted onto PVDF membranes (Millipore, Bradford,
MA, USA), and incubated with polyclonal rabbit anti-cebpβ (1:1000) and monoclonal mouse
anti-tubulin (1:5000) (Santa-Cruz Biotech, CA, USA) overnight and afterwards with polyclonal
goat anti-mouse IgG-HRP for cebpβ (1:5000) and polyclonal goat anti-rabbit for α-tubulin
(1:5000) (Santa-Cruz Biotech, CA, USA) for 2 hours. Bound antibodies were visualized by an
Table 2. Primers for PCR amplification of each studied gene.
Sense primer Anti-sense primer
srebf1 5´- AAATCTTGCTGCCATTCG -3´ 5´- TTGATCCCGGAAGCTCTGTG -3´
klf5 5´- CCGGAGACGATCTGAAACAC -3´ 5´- GGAGCTGAGGGGTCAGATACTT -3´
creb1 5´- TTTGTCCTTGCTTTCCGAAT -3´ 5´- CACTTTGGCTGGACATCTTG -3´
lxrα 5´- ATCGCCTTGCTGAAGACCTCTG -3´ 5´- GATGGGGTTGATGAACTCCACC -3´
18s 5´- GTGGGCCTGCGGCTTAAT -3´ 5´- GCCAGAGTCTCGTTCGTTATC -3´
Sterol regulatory element binding transcription factor 1 (srebf1); kru¨ppel-like factor 5 (klf5); cAMP responding element binding protein 1 (creb1), liver x
receptor α (lxrα); 18S ribosomal RNA (18s).
https://doi.org/10.1371/journal.pone.0184875.t002
miRNA modification induced by resveratrol and its metabolites
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ECL system (Thermo Fisher Scientific Inc., Rockford, IL, USA) and quantified by Chemi-Doc
MP imaging system (BioRad, CA, USA).
Statistical analysis
Results are presented as mean ± standard error of the mean. Statistical analysis was performed
using SPSS 24.0 (SPSS Inc. Chicago, IL, USA). Comparisons between each treatment and the
controls were analyzed by Student’s t test. Statistical significance was set-up at the p< 0.05
level.
Results and discussion
As stated in the introduction section, obesity is a real problem, and functional molecules may
be a new effective tool for the management of this disease. Among them, resveratrol has been
demonstrated as having beneficial effects in order to face obesity in both in vitro and in vivo
models. Several published in vitro studies conclude that this polyphenol is able to inhibit the
process of adipogenesis, leading to a lower amount of differentiated adipocytes and thus to a
decrease in triglyceride accumulation [49–51]. Along the same lines, we previously demon-
strated that resveratrol and its glucuronide and sulfate metabolites are able to block adipogen-
esis and to reduce triglyceride accumulation to the same extent in 3T3-L1 maturing pre-
adipocytes [25].
Adipogenesis is a complex process governed by a tightly controlled network of transcrip-
tion factors that coordinate a great number of genes [52–55]. At the centre of this network
there are two principal adipogenic factors, pparγ and cebpα, whose expression is regulated by
other transcription factors, such as cebpβ [27]. In recent years, miRNAs have been described as
a potential group of adipogenic controllers. Indeed, a snapshot of miRNA profiling revealed a
dramatic change of 21 miRNAs during 3T3-L1 adipocyte differentiation [56]. In this line,
miR-155 and miR-27b have been shown to suppress the expression of cebpβ and pparγ in adi-
pocytes. Therefore, these miRNAs could be considered one of the mechanisms by which the
adipogenic process is inhibited [16, 35, 42].
Modulation of miRNA expression by dietary compounds is increasingly being investigated
by scientists working in the field of functional ingredients and their potential capacity to pre-
vent pathologies. Indeed, some dietary polyphenols, such as curcumin, epigallocatechin gallate
or resveratrol have been demonstrated to suppress different cancer cells growth by up-regulat-
ing miRNAs [57]. Resveratrol has also been linked to modifications on miRNAs expression in
heart myoblasts, which could explain its cardioprotective effect. Quercetin, coffee polyphenols
and grape seed proanthocyanidins can target miR-122 in mice livers and control cholesterol
and bile acid synthesis and fatty acid oxidation, and thus, prevent liver steatosis [58, 59]. With
regard to regulation of adipogenesis through miRNAs, Zhu et al. demonstrated that epigalloca-
tequines up-regulated the expression of miR-27a and miR-27b and down-regulated that of
pparγ and cebpα [60]. The same effects were found by persimmon tannin treatment during
adipogenesis [43]. By contrast, it seems that nonivamide, a capsaicin analogue, increases the
expression of the miRNA mmu-let-7d-5p, which has been associated with decreased pparγ lev-
els [61]. Other plant or fruit extracts have been also identified as adipogenic regulators via
miRNAs [62, 63].
In view of all mentioned above, and considering that miRNAs can play a crucial role in the
effect attributed to dietary polyphenols, in the present study we aimed to analyze the mecha-
nisms by which RSV and its metabolites modified the gene expression of adipogenic regula-
tors. For this purpose we focussed on the analysis of those potential miRNA (validated or
miRNA modification induced by resveratrol and its metabolites
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predicted) targeting pparγ, cebpβ and cebpα, which were selected by using the miRWalk 2.0.
database and a literature review.
MiR-155 and other genes that regulate the expression of cebpβ were measured (Table 1).
RSV and the glucuronide metabolites increased miR-155 gene expression, but 3S metabolite
did not (Fig 1A). These results could suggest that whereas RSV, 3G and 4G exert their effect
via miR-155, 3S metabolite does not do so. In order to verify the mechanism of RSV and the
glucuronide metabolites, maturing 3T3-L1 adipocytes were transfected with an anti-miR-155
compound while they were cultured in the presence or absence of RSV. After transfection,
cebpβ gene and protein expression remained unchanged in treated cells (Fig 2), demonstrating
that the polyphenol, and reportedly its glucuronide metabolites, inhibit the process of adipo-
genesis, at least in part, via miR-155. The modulation of miR-155 by RSV has been extensively
studied in monocytes and macrophages. In these cells RSV was shown to increase miR-155
expression, to reduce the inflammatory response and to protect from atherosclerosis and
hypertension [64–67]. Nevertheless, studies analyzing this regulatory pathway in adipocytes
have not been carried out yet.
Taking into account that the sulfate metabolite did not exert any effect on miR-155 (Fig
1A), other regulatory routes that could lead to the reduction observed in cebpβ gene expression
were analyzed. In the network of adipogenic transcription factors creb1 plays a crucial role as
cebpβ precursor [68–70]. Moreover, klf5 is induced by cebpβ/δ and in turn controls pparγ
Fig 1. Effects of 25 μM of resveratrol (RSV) on the expression of mir-155 (A) and 25 μM of trans-resveratrol-
3-O-sulfate (3S), trans-resveratrol-3-O-glucuronide (3G) and trans-resveratrol-4-O-glucuronide (4G) on creb1
and klf5 gene expression (B) in 3T3-L1 maturing pre-adipocytes treated from day 0 to day 8. Values are
means ± SEM (Standard Error of the Mean) of three independent experiments carried out in sextuplicate.
Comparisons between each treatment and the controls were analyzed by Student’s t-test. The asterisks
represent differences versus the controls (*P < 0.05; **P < 0.01; ***P < 0.001).
https://doi.org/10.1371/journal.pone.0184875.g001
miRNA modification induced by resveratrol and its metabolites
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expression, thus mediating both the early and late stages of the differentiation program [71].
In the present study, 3S metabolite reduced gene expression of creb1 and 3S and 4G that of klf5
(Fig 1B). Therefore, it could be suggested that 3S metabolite orchestrated its effects on the ini-
tial phase of the adipogenesis in a transcriptional way, apparently without any influence of
miRNA. By contrast, the 4G metabolite not only exerted its effect via miR-155, but also
through klf5. The modulation of cebpβ was also observed by other polyphenols [72, 73].
MiR-27b, miR-27a and miR-130b were selected by miRWalk database (Table 1) as pparγ
regulator. Sulfate metabolite did not change the expression of these miRNAs (Fig 3A). As in
the case of cebpβ, other genes that are involved in the regulation of pparγ during adipogenesis
(srebf1 and lxrα) [74, 75] were analyzed. 3S metabolite reduced the expression of both genes
(Fig 3B), which explains the changed induced by this metabolite in pparγ expression without
changes in miR-27b, miR-27a and miR-130b. This fact was also observed with other anti-adi-
pogenic pytochemicals such as apigenin [76], or black adzuki bean [77].
Finally, we set out to analyze the miRNAs related to cebpα. For this purpose, miR-326, miR-
31, miR-144, miR-205 and miR-224 were selected as miRNAs targeting cebpα, according to
the computational analysis and literature (Table 1). None of these miRNAs were modified by
3S treatment (Fig 4), which suggests that its mechanism of action was not via miRNAs. The
Fig 2. cebpβ gene (A) and protein (B) expressions after transfection with miR-155 inhibitor, with or without
25 μM RSV in 3T3-L1 maturing pre-adipocytes treated from day 0 to day 2. Values are means ± SEM
(Standard Error of the Mean) of three independent experiments carried out in triplicate. Comparisons between
each treatment and the controls were analyzed by Student’s t-test. The asterisks represent differences versus
the controls (*P < 0.05).
https://doi.org/10.1371/journal.pone.0184875.g002
miRNA modification induced by resveratrol and its metabolites
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Fig 3. Effects of 25 μM of trans-resveratrol-3-O-sulfate (3S) on the expression of mir-27b, miR-27a and miR-
130b (A) and on gene expression of srebf1 and lxrα (B) in 3T3-L1 maturing pre-adipocytes treated from day 0
to day 8. Values are means ± SEM (Standard Error of the Mean) of three independent experiments carried out
in sextuplicate. Comparisons between each treatment and the controls were analyzed by Student’s t-test. The
asterisks represent differences versus the controls (*P < 0.05; ***P < 0.001).
https://doi.org/10.1371/journal.pone.0184875.g003
Fig 4. Effects of 25 μM of trans-resveratrol-3-O-sulfate (3S) on the expression of miR-326, miR-31, miR-
144, miR-205 and miR-224 in 3T3-L1 maturing pre-adipocytes treated from day 0 to day 8. Values are
means ± SEM (Standard Error of the Mean) of three independent experiments carried out in sextuplicates.
Comparisons between each treatment and the controls were analyzed by Student’s t-test.
https://doi.org/10.1371/journal.pone.0184875.g004
miRNA modification induced by resveratrol and its metabolites
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down-regulation observed by 3S on pparγ, can be considered itself one of the reasons for
reduction in cebpα. These results, as a whole, suggest that 3S metabolite could exert its anti-
adipogenic effect through adipogenic regulatory genes but not through miRNAs, as is the case
of resveratrol and glucuronide metabolites (Fig 5).
This study presents the limitation that the experiments were performed in 3T3-L1 adipo-
cytes. Therefore, data extrapolation to human is not completely possible. There are some
differences in the metabolism and physiology of mouse and human adipogenesis such as dif-
ferences in the modulation of pparγ [78]. However, the main species-specific differences in
adipogenesis focus on when (and where) the products of the genes are made. However, the
role of the master regulators is the same in both species, as far as we know. Taking into account
the methodological difficulties that human adipocytes present for transfections and the hetero-
geneity of results in response to treatments, 3T3-L1 adipocytes were used in the present study.
Conclusions
In summary, our study clearly suggests that the inhibitory effect on adipogenesis attributed to
RSV and its glucuronide metabolites (3G and 4G) in 3T3-L1 adipocytes is mediated by the up-
Fig 5. Genes and miRNAs involved in the inhibition of adipogenesis by resveratrol (RSV), trans-resveratrol-3-O-sulfate (3S), trans-resveratrol-3-O-
glucuronide (3G) and trans-resveratrol-4-O-glucuronide (4G) in the pathways of the adipogenic process (modified from Farmer et. al. 2006).
https://doi.org/10.1371/journal.pone.0184875.g005
miRNA modification induced by resveratrol and its metabolites
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regulation of miR-155, which in turn leads to a down-regulation of cebpβ gene expression. In
the case of 4G, klf5 also contributed to this regulation. By contrast, the inhibitory effect
observed in cells treated with 3S metabolite was not mediated via miRNAs. In this case,
changes in creb1, klf5, srebf1 and lxrα, explain the effects of this metabolite on adipogenesis.
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